XML 65 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Quarterly Financial Data (Unaudited) | 12 Months Ended
--- | ---
Sep. 30, 2012
Quarterly Financial Data (Unaudited) [Abstract] |
Quarterly Financial Data (Unaudited) |
12. | Quarterly Financial Data (Unaudited)
The following is a summary of the unaudited quarterly results for the years ended September 30, 2012 and 2011 (in thousands, except per share data).
|  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |
Fiscal 2012 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 11,916 |  |  | $ | 12,210 |  |  | $ | 13,959 |  |  | $ | 13,843 |
Operating income from continuing operations |  |  | 3,222 |  |  |  | 3,689 |  |  |  | 4,793 |  |  |  | 4,638 |
Income from continuing operations |  |  | 2,155 |  |  |  | 1,946 |  |  |  | 3,174 |  |  |  | 2,854 |
Income (loss) from discontinued operations |  |  | 551 |  |  |  | (223 | ) |  |  | (112 | ) |  |  | (114 | )
Net income |  |  | 2,706 |  |  |  | 1,723 |  |  |  | 3,062 |  |  |  | 2,740 |
Basic income (loss) per share(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  |  | 0.12 |  |  |  | 0.11 |  |  |  | 0.18 |  |  |  | 0.17 |
Discontinued operations |  |  | 0.03 |  |  |  | (0.01 | ) |  |  | (0.01 | ) |  |  | (0.01 | )
Net income |  |  | 0.15 |  |  |  | 0.10 |  |  |  | 0.17 |  |  |  | 0.16 |
Diluted income (loss) per share(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  |  | 0.12 |  |  |  | 0.11 |  |  |  | 0.18 |  |  |  | 0.17 |
Discontinued operations |  |  | 0.03 |  |  |  | (0.01 | ) |  |  | (0.01 | ) |  |  | (0.01 | )
Net income |  |  | 0.15 |  |  |  | 0.10 |  |  |  | 0.17 |  |  |  | 0.16 |
Fiscal 2011 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 12,522 |  |  | $ | 13,334 |  |  | $ | 12,999 |  |  | $ | 13,901 |
Operating income from continuing operations |  |  | 4,121 |  |  |  | 4,212 |  |  |  | 4,257 |  |  |  | 2,933 |
Income from continuing operations |  |  | 2,860 |  |  |  | 2,824 |  |  |  | 3,051 |  |  |  | 2,190 |
(Loss) income from discontinued operations |  |  | (9,031 | ) |  |  | (336 | ) |  |  | 791 |  |  |  | (20,855 | )
Net (loss) income |  |  | (6,171 | ) |  |  | 2,488 |  |  |  | 3,842 |  |  |  | (18,665 | )
Basic income (loss) per share(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  |  | 0.16 |  |  |  | 0.16 |  |  |  | 0.17 |  |  |  | 0.13 |
Discontinued operations |  |  | (0.52 | ) |  |  | (0.02 | ) |  |  | 0.05 |  |  |  | (1.20 | )
Net (loss) income |  |  | (0.36 | ) |  |  | 0.14 |  |  |  | 0.22 |  |  |  | (1.07 | )
Diluted income (loss) per share(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  |  | 0.16 |  |  |  | 0.16 |  |  |  | 0.17 |  |  |  | 0.13 |
Discontinued operations |  |  | (0.52 | ) |  |  | (0.02 | ) |  |  | 0.05 |  |  |  | (1.19 | )
Net (loss) income |  |  | (0.35 | ) |  |  | 0.14 |  |  |  | 0.22 |  |  |  | (1.07 | )
(1) | The sum of the quarterly income (loss) per share may not equal the annual income (loss) per share because of changes in the weighted average number of shares outstanding that occurred during the year.
In the second quarter of fiscal 2012, the Company recorded an $0.8 million impairment loss on its investment in OctoPlus. In the fourth quarter of fiscal 2012, the Company recorded $0.5 million of costs associated with its “modified Dutch auction” tender offer. In the first quarter of fiscal 2011, the Company recorded a $0.6 million restructuring charge in connection with the reorganization announced in October 2010, included in the operating results from continuing operations, and a $5.7 million goodwill impairment charge and $0.6 million restructuring charge in connection with the reorganization announced in October 2010, associated with the Company’s SurModics Pharmaceuticals reporting unit which have been included in the operating results of discontinued operations. In the fourth quarter of fiscal 2011, the Company recorded a $1.0 million restructuring charge in connection with the reorganization announced in August 2011, included in the operating results from continuing operations, and $28.1 million of asset impairment charges associated with the write-down of the long-lived assets of the SurModics Pharmaceuticals segment, included in the operating results of discontinued operations.

X
- Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=20225539&loc=d3e1280-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section G -Subsection 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 28 -Paragraph 30 -Subparagraph a-j -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 28 -Paragraph 23, 24 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K (SK) -Number 229 -Section 302 -Paragraph a + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration